adenosine diphosphate has been researched along with Angina at Rest in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (26.32) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Herbert, JM; Savi, P | 1 |
| Fang, L; Jiao, KL; Lin, YJ; Liu, B; Meng, S | 1 |
| Badimon, JJ; Burg, MM; Chaplin, W; Davidson, KW; Fuster, V; Paz-Yepes, M; Shimbo, D; Vilahur, G; Zafar, MU | 1 |
| Jannati, M; Khalili, A; Kojuri, J; Mahboodi, A; Mahmoody, Y; Zangbar Sabegh, B | 1 |
| Bolton, ED; Braunstein, JB; Chiles, KA; Faraday, N; Gerstenblith, G; Heldman, AW; Schulman, SP | 1 |
| Crea, F; Infusino, F; Lanza, GA; Navarese, EP; Sestito, A; Sgueglia, GA; Spinelli, A | 1 |
| Cicha, I; Daniel, WG; Garlichs, CD; Klinghammer, L; Lohmann, T; Raaz, D; Stumpf, C; Wallaschofski, H; Yilmaz, A | 1 |
| Théroux, P; Xiao, Z | 1 |
| Bunting, S; Hariawala, MD; Laham, RJ; Li, J; Sellke, FW; Simons, M; Tofukuji, M | 1 |
| Eto, K; Isshiki, T; Ochiai, M; Ozaki, Y; Sato, T; Takeshita, S | 1 |
| Fitzgerald, DJ; Quinn, MJ | 1 |
| Eisenberg, PR; Gretler, D; Harrington, RA; Jennings, LK; Joseph, DM; Kleiman, NS; Labinaz, M; Lincoff, AM; McDougal, MF; Potthoff, RF; Tardiff, BE; Vorchheimer, DA | 1 |
| Ferguson, JJ; Kim, P; Villareal, RP; Wilson, JM | 1 |
| Diodati, J; Lacoste, L; Lam, JY; Latour, JG; Théroux, P; Waters, D | 1 |
| Kendrew, PJ; Nidorf, SM; Strophair, J; Sturm, M; Taylor, RR | 1 |
| Bleifeld, W; Hamm, CW; Kupper, W; Terres, W | 1 |
| De Lara, J; Latour, JG; Léger-Gauthier, C; Théroux, P | 1 |
| Grande, P; Grauholt, AM; Wadt, J | 1 |
| Swahn, E; Wallentin, L | 1 |
3 review(s) available for adenosine diphosphate and Angina at Rest
| Article | Year |
|---|---|
P2Y12, a new platelet ADP receptor, target of clopidogrel.
Topics: Adenosine Diphosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Down-Regulation; Humans; Membrane Proteins; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stroke; Ticlopidine | 2003 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bone Marrow Diseases; Carbamazepine; Cardiovascular Diseases; Clopidogrel; Combined Modality Therapy; Coronary Disease; Drug Interactions; Hemorrhage; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Phenytoin; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Safety; Stents; Theophylline; Thrombolytic Therapy; Ticlopidine | 1999 |
Unstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapy.
Topics: Adenosine Diphosphate; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Drug Therapy, Combination; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2001 |
6 trial(s) available for adenosine diphosphate and Angina at Rest
| Article | Year |
|---|---|
Antiplatelet and myocardial protective effect of Shexiang Tongxin Dropping Pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial.
Topics: Adenosine Diphosphate; Angina, Unstable; Animals; Biomarkers; Clopidogrel; Cytochrome P-450 CYP2C19; Drugs, Chinese Herbal; Galectin 3; Humans; Intercellular Adhesion Molecule-1; Male; Mice; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Vascular Cell Adhesion Molecule-1 | 2022 |
Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
Topics: Adenosine Diphosphate; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Chi-Square Distribution; Coronary Artery Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Humans; Iran; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Assessment; Risk Factors; Sex Factors; Smoking; Stents; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2010 |
Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Aged; Angina, Unstable; Arachidonic Acid; Aspirin; Blood Platelets; C-Reactive Protein; Cell Aggregation; Drug Resistance; Eptifibatide; Female; Heparin; Humans; Leukocytes; Male; Middle Aged; Monocytes; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Neutrophils; Patient Selection; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Receptors, Thrombin; Recurrence; ROC Curve; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2004 |
Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angina, Unstable; Anticoagulants; Antithrombins; Arginine; Dose-Response Relationship, Drug; Enoxaparin; Female; Heparin; Humans; Male; Middle Aged; P-Selectin; Partial Thromboplastin Time; Peptide Fragments; Pipecolic Acids; Platelet Activation; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Sulfonamides | 1998 |
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.
Topics: Adenosine Diphosphate; Aged; Amino Acid Chloromethyl Ketones; Angina, Unstable; Antithrombins; Coronary Disease; Eptifibatide; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Time Factors | 2001 |
The influence of fenflumizole on platelet aggregation in patients with unstable angina pectoris.
Topics: Adenosine Diphosphate; Adult; Aged; Angina Pectoris; Angina, Unstable; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; beta-Thromboglobulin; Clinical Trials as Topic; Collagen; Female; Humans; Imidazoles; Male; Middle Aged; Platelet Aggregation; Platelet Factor 4; Thromboxane B2; Verapamil | 1987 |
10 other study(ies) available for adenosine diphosphate and Angina at Rest
| Article | Year |
|---|---|
Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression.
Topics: Adenosine Diphosphate; Aged; Angina, Unstable; Anxiety Disorders; Aspirin; Clopidogrel; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Serotonin; Ticlopidine | 2010 |
Increased platelet reactivity in unstable angina patients is not related to C-reactive protein levels.
Topics: Adenosine Diphosphate; Aged; Angina, Unstable; C-Reactive Protein; Collagen; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation; Statistics as Topic; Statistics, Nonparametric | 2006 |
Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression.
Topics: Adenosine Diphosphate; Aged; Angina, Unstable; Blood Platelets; Coronary Disease; Female; Flow Cytometry; Humans; Leptin; Male; Myocardial Infarction; P-Selectin; Prolactin | 2006 |
Comparison of VEGF delivery techniques on collateral-dependent microvascular reactivity.
Topics: Adenosine Diphosphate; Angina, Unstable; Animals; Collateral Circulation; Coronary Circulation; Drug Delivery Systems; Endothelial Growth Factors; Female; Lymphokines; Male; Microcirculation; Myocardial Ischemia; Neovascularization, Physiologic; Swine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vasodilation | 1998 |
Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability.
Topics: Acute Disease; Adenosine Diphosphate; Adrenergic Agonists; Adult; Aged; Aged, 80 and over; Analysis of Variance; Angina, Unstable; Blood Coagulation Tests; Case-Control Studies; Coronary Disease; Epinephrine; Female; Humans; Lasers; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Scattering, Radiation | 1998 |
Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction.
Topics: Adenosine Diphosphate; Angina Pectoris; Angina, Unstable; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombin; Time Factors | 1990 |
Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina.
Topics: Adenosine Diphosphate; Aged; Angina Pectoris; Angina, Unstable; Collagen; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Activating Factor; Platelet Aggregation; Thromboxane B2 | 1989 |
[Thrombocyte function in unstable angina pectoris].
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Alprostadil; Angina Pectoris; Angina, Unstable; Blood Platelets; Collagen; Coronary Disease; Cyclic AMP; Humans; Infant; Platelet Aggregation; Prospective Studies | 1988 |
Fibrinopeptide A and platelet factor levels in unstable angina pectoris.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Angina Pectoris; Angina, Unstable; beta-Thromboglobulin; Coronary Angiography; Fibrinogen; Fibrinopeptide A; Heart Ventricles; Humans; Physical Exertion; Platelet Aggregation; Platelet Factor 4; Thromboxane B2; Time Factors | 1987 |
Platelet reactivity in unstable coronary artery disease.
Topics: Acute Disease; Adenosine Diphosphate; Adult; Angina, Unstable; beta-Thromboglobulin; Blood Platelets; Collagen; Coronary Disease; Epoprostenol; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Factor 4; Sex Factors | 1987 |